TechCrunch
SEPTEMBER 9, 2021
Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used to launch virtual neurology clinics and to support Neuroglee’s move to Boston. Neuroglee gets $2.3
TechCrunch
MARCH 14, 2022
startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based based VC firm Optum Ventures, as it gears up to hop over the pond. Vira Health , a U.K.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
NOVEMBER 3, 2021
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.
TechCrunch
FEBRUARY 10, 2022
With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. The company’s AI chatbot RONI, which was launched in December, supports human professionals by providing recommended answers, Kim said. .
American Entrepreneurship
JANUARY 18, 2024
The inaugural cohort marks an important milestone in the NJEDA’s commitment to fostering innovation and supporting business ventures in their critical early stages. By supporting these 10 new, cutting-edge companies, New Jersey is firmly cementing itself as a national leader in innovation.” million in bonus grant funding.
Angel Capital Association
MAY 18, 2020
MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
TechCrunch
MAY 12, 2023
Similar to most other sectors today, that crumbling of confidence in the sector has trickled down to the private markets as well, slowing down venture dealmaking and further shrinking deal sizes in an already parched venture market. Will they take the lead?” It is therefore our goal to focus on the regulated paths (e.g.,
Expert insights. Personalized for you.
93 
Let's personalize your content